Bonita David P's Form 4 filing
Repare Therapeutics Inc. (RPTX) · filed Sep 2, 2021
- Accession no.
- 0000947871-21-000978
- Filed
- Sep 2, 2021
- Trade date
- Aug 31-Sep 2, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market sales total $1.29M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bonita David PCIK 0001572451 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2021 | Common Stock | SSaleDisposed | −8,223 | $33.94 | −$279,088.62 | 3,213,414 | Indirect | |
| Aug 31, 2021 | Common Stock | SSaleDisposed | −249 | $33.94 | −$8,451.06 | 97,293 | Indirect | |
| Sep 1, 2021 | Common Stock | SSaleDisposed | −12,586 | $33.98 | −$427,672.28 | 3,200,828 | Indirect | |
| Sep 1, 2021 | Common Stock | SSaleDisposed | −382 | $33.98 | −$12,980.36 | 96,911 | Indirect | |
| Sep 2, 2021 | Common Stock | SSaleDisposed | −15,941 | $34.24 | −$545,819.84 | 3,184,887 | Indirect | |
| Sep 2, 2021 | Common Stock | SSaleDisposed | −483 | $34.24 | −$16,537.92 | 96,428 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.